Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID07517900

A Clinical Safety Study of 1 Mitopure Topical Product in 30 Healthy Volunteers to Assess Skin Safety After Repeated Applications

Led by Amazentis SA · Updated on 2026-05-28

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

A

Amazentis SA

Lead Sponsor

P

Princeton Consumer Research

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the safety of a topical skin serum containing Mitopure in healthy adult volunteers. The study aims to assess any skin irritation or reactions after repeated applications of the test product. This clinical safety study involves a group of 30 healthy participants to understand how the product affects the skin over a short period. Participants will apply the Mitopure topical formula regularly as instructed during the study. They must only use this test article on themselves and avoid other facial serum products, cleansers, detergents, or fragrances throughout the study. The study does not involve a placebo or comparison group and does not use masking or blinding. Volunteers will attend all scheduled study visits where their skin will be examined for irritation and other traits related to product use. Researchers will monitor skin condition closely over two weeks to observe any changes or reactions. Participants will be asked to refrain from new medications or supplements unless allowed by the investigator, and the total study duration aligns with the two-week safety assessment period.

CONDITIONS

Brief Title

Human Skin Safety Testing of 1 Mitopure Topical Product Using a Clinical Safety in Use Study in Healthy Volunteers

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy male and female participants aged 18 years or older
  • Signed a written Informed Consent
  • Agree to avoid new medications or herbal supplements during the study unless permitted by the investigator
  • Do not have grade 3 or higher of any skin attribute according to the grading scale
  • Willing to use only the test article on themselves and not use other facial serum products during the study
  • Willing to attend all study visits and follow study instructions and prohibitions
  • Agree to avoid using new facial serum products, cleansers, laundry detergents, and fragrances during the study
Not Eligible

You will not qualify if you...

  • Pregnant, nursing, or planning to become pregnant
  • Current skin diseases such as eczema, psoriasis, rosacea, atopic dermatitis, or vitiligo
  • Known allergy to face serum products or ingredients in the test article
  • History of malignant disease
  • Cuts, scratches, abrasions, rashes, scarring, birthmarks, or tattoos on the face that may interfere with assessments
  • Significant past medical history of hepatic, renal, cardiac, pulmonary, digestive, hematological, neurological, locomotor, or psychiatric disease
  • Known sensitivity to the test article or similar materials
  • Use of sympathomimetics, antihistamines, or corticosteroids within seven days prior to study start
  • Any medical condition that may affect study data or participant safety as judged by the investigator
  • History of poor cooperation, non-compliance, or unreliability
  • Investigator deems the participant unsuitable for the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 2 weeks

Participants apply the Mitopure Topical Formula to their skin repeatedly to assess skin safety.

Multiple visits during the 2 weeks as needed for assessments

Trial Site Locations

Total: 1 location

1

PCR Corp

Manchester, United Kingdom, M13 0AF

Actively Recruiting

Loading map...

Research Team

B

Brad Currier, PhD

A

Anurag Singh, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Similar Trials

A Novel Accessible and Widespread Healthcare Service Model B...

Parkinson Disease

Actively Recruiting

5 locations

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmaco...

Healthy Adult

Actively Recruiting

1 location

An Open-label, Randomized, Single-dose, Two-Cohort, Two-Peri...

Healthy Adult

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here